Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Fortress Biotech (FBIO) over the last 13 years, with Q3 2025 value amounting to $116.2 million.

  • Fortress Biotech's Total Liabilities fell 1687.92% to $116.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $116.2 million, marking a year-over-year decrease of 1687.92%. This contributed to the annual value of $145.9 million for FY2024, which is 1209.6% down from last year.
  • Fortress Biotech's Total Liabilities amounted to $116.2 million in Q3 2025, which was down 1687.92% from $122.5 million recorded in Q2 2025.
  • Fortress Biotech's Total Liabilities' 5-year high stood at $244.3 million during Q4 2022, with a 5-year trough of $116.2 million in Q3 2025.
  • In the last 5 years, Fortress Biotech's Total Liabilities had a median value of $168.6 million in 2024 and averaged $176.3 million.
  • Its Total Liabilities has fluctuated over the past 5 years, first skyrocketed by 6316.59% in 2021, then crashed by 3206.91% in 2023.
  • Quarter analysis of 5 years shows Fortress Biotech's Total Liabilities stood at $170.6 million in 2021, then soared by 43.16% to $244.3 million in 2022, then tumbled by 32.07% to $165.9 million in 2023, then decreased by 12.1% to $145.9 million in 2024, then decreased by 20.32% to $116.2 million in 2025.
  • Its last three reported values are $116.2 million in Q3 2025, $122.5 million for Q2 2025, and $145.6 million during Q1 2025.